Aging
Navigate
Back to articleFigure 12(12 of 12)
100%
Figure 12
Figure 12.Durg-response analysis of (A) Paclitaxel. (B) Camptothecin. (C) Cytarabine. (D) Lapatinib. (E) Erlotinib. (F) Gefitinib.
Figure 12 — Tumor microenvironment-related multigene prognostic prediction model for breast cancer | Aging